Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:Covance_Drug_Development
gptkb:OmniSeq gptkb:Genomic_Health Covance Sequenom |
| gptkbp:CEO |
gptkb:Adam_H._Schechter
|
| gptkbp:employees |
over 70,000
|
| gptkbp:focus |
clinical trials
data analytics laboratory testing patient recruitment clinical research commercialization services regulatory consulting biomarker_development |
| gptkbp:focus_area |
mental health
quality assurance metabolic disorders neurology oncology pediatrics personalized medicine rare diseases autoimmune diseases chronic diseases data science market access safety monitoring biostatistics infectious diseases women's health health economics real-world evidence geriatrics regulatory affairs clinical pharmacology cardiovascular healthcare_technology |
| gptkbp:founded |
1971
|
| gptkbp:headquarters |
gptkb:Burlington,_North_Carolina
|
| https://www.w3.org/2000/01/rdf-schema#label |
LabCorp Drug Development
|
| gptkbp:operates_in |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:partnerships |
gptkb:FDA
gptkb:NCI academic institutions various pharmaceutical companies biotech companies |
| gptkbp:revenue |
$12 billion (2020)
|
| gptkbp:services |
clinical laboratory services
drug development services |
| gptkbp:subsidiary |
gptkb:LabCorp_Drug_Development_Services
gptkb:LabCorp_Diagnostics gptkb:LabCorp_Clinical_Trials Covance |
| gptkbp:website |
www.labcorp.com
|